Generic Domperidone

Buy cheap Generic Domperidone () without dr prescription at Canadian Pharmacy

Domperidone (10 mg): Comprehensive Patient Information for Canada

Basic Product Information

Mechanism of Action

In simple terms: Domperidone is a medication that helps the stomach empty faster and prevents nausea and vomiting. It works by blocking the effects of a natural substance called dopamine in the gut and in the brain's vomiting centre. By doing this, it speeds up the movement of food through the stomach and upper intestine, and it stops the signals that trigger the urge to vomit. Unlike some other anti-nausea medications, it does not easily enter the brain, which means it is less likely to cause drowsiness or movement side effects.

For specialists: Domperidone is a dopamine antagonist with antiemetic properties. It is a peripheral dopamine D2 receptor antagonist that does not readily cross the blood-brain barrier. Its antiemetic effect is due to a combination of peripheral (gastrokinetic) effects and antagonism of dopamine receptors in the chemoreceptor trigger zone, which is located outside the blood-brain barrier in the area postrema. Domperidone increases the mild digestive contractions of the esophagus and stomach and helps to more effectively coordinate the emptying of food from the stomach into the intestine. It also helps to more effectively move digesting food material through the small intestine. Domperidone stimulates prolactin release from the pituitary gland. It is structurally related to the benzimidazoles and blocks both D1 and D2 receptors.

Pharmacokinetics

• Absorption: In fasting subjects, domperidone is rapidly absorbed after oral administration, with peak plasma concentrations occurring approximately 30 to 60 minutes after dosing. Due to extensive intestinal wall and hepatic first-pass metabolism, the absolute oral bioavailability is low (approximately 15%). Taking domperidone after meals may slightly delay the time to peak concentration but slightly increases the AUC. Reduced gastric acidity decreases the absorption of domperidone.
• Metabolism: Domperidone undergoes rapid and extensive metabolism in the liver through hydroxylation and N-dealkylation. CYP3A4 is the major cytochrome P450 enzyme involved in the N-dealkylation of domperidone. CYP3A4, CYP1A2, and CYP2E1 are involved in the aromatic hydroxylation of domperidone.
• Elimination: Urinary and fecal excretion account for 31% and 66% of the oral dose, respectively. Only a small fraction of the drug is excreted unchanged (10% in feces and about 1% in urine). The plasma half-life after a single oral dose in healthy subjects is 7 to 9 hours, and may be prolonged in patients with severe renal impairment.
• Distribution: Domperidone is more than 90% bound to plasma proteins. Animal studies using radiolabeled drug show high tissue distribution, but brain concentrations are very low. A small amount of drug crosses the placenta in rats.
• Onset of Action: Following oral administration, domperidone begins to take effect within approximately 30 to 60 minutes. It is typically taken 15 to 30 minutes before meals.
• Duration of Action: The antiemetic and prokinetic effects typically last for several hours following a single dose.

Uses in Daily Life and Best Practice Advice

Domperidone is prescribed in Canada for the treatment of nausea and vomiting and for conditions involving delayed stomach emptying. Your physician will determine the appropriate use and dose based on your specific medical situation.

• Typical Uses: Treatment of symptoms of slowed stomach emptying (gastroparesis) seen in people with some gastrointestinal disorders (e.g., gastritis — inflammation of the GI tract); prevention of symptoms such as nausea and vomiting caused by some drugs used to treat Parkinson's disease. Domperidone is commonly used for chemotherapy-induced nausea and vomiting, especially when patients cannot tolerate other antiemetics that may cause extrapyramidal side effects.
• Administration: Take the tablet orally before meals. If taken after meals, absorption is somewhat delayed. Swallow the tablet whole with water. The recommended adult dose is 10 mg three times daily, taken 15 to 30 minutes before meals. The maximum daily dose is 30 mg.
• Monitoring: If symptoms do not improve within a reasonable period, or if they worsen, consult your physician. The maximum recommended treatment duration is generally one week. Use the lowest effective dose for the shortest possible duration. Evaluate efficacy after 4 to 8 weeks to determine if continuation is warranted.
• Do Not Exceed Recommended Dose: Do not take more than the prescribed dose. The maximum recommended daily dose is 30 mg. Doses above 10 mg three times daily are not recommended due to QT prolongation risk.

Morning vs. Evening Dosing

Domperidone is typically taken three times daily, with doses spaced throughout the day. For best results, take it 15 to 30 minutes before meals. There is no specific clinical recommendation for morning versus evening dosing beyond the meal-related timing. Always follow the schedule recommended by your physician.

• Before Meals: Taking domperidone before meals helps with delayed stomach emptying and prevents nausea associated with eating. If taken after meals, absorption is somewhat delayed.
• Consistency: Take domperidone at the same times each day to ensure consistent effects.
• Missed Dose: If you miss a dose, skip the missed dose and resume your usual dosing schedule. Do not take a double dose to make up for a forgotten dose.
• Maximum Duration: Normally, the maximum treatment duration should not exceed one week. For gastroparesis, evaluate efficacy after 4 to 8 weeks to determine if continuation is warranted.

Administration With or Without Food

Domperidone should be taken before meals. This timing allows the medication to be absorbed and reach the gastrointestinal tract before food enters, maximizing its prokinetic and antiemetic effects. If taken after meals, absorption is somewhat delayed.

• Take the tablet with a full glass of water.
• Take domperidone 15 to 30 minutes before each meal as prescribed.
• Swallow the tablet whole. Do not crush or chew unless directed by your pharmacist.
• Antacids or antisecretory drugs should not be taken at the same time as domperidone, as they reduce the oral bioavailability of domperidone.

Interaction Warnings

Indications for Domperidone

"Off-label" means use outside the official approved indication, usually based on current medical guidelines and scientific evidence.

Dosing According to Clinical Indication

Doses should always be adjusted according to the advice of your physician and depending on your health condition. Domperidone is contraindicated in patients with moderate or severe hepatic impairment, prolactin-releasing pituitary tumour (prolactinoma), or conditions where gastrointestinal stimulation could be dangerous (e.g., gastrointestinal obstruction, perforation, or hemorrhage).

Side Effects and Safety Profile

Guidelines for Correct Use

• Take domperidone exactly as prescribed by your physician. Do not change your dose without medical advice.
• Take the tablet with a full glass of water, 15 to 30 minutes before meals.
• Do not exceed the maximum daily dose of 30 mg.
• Use the lowest effective dose for the shortest possible duration. The maximum treatment duration is generally one week for acute nausea and vomiting.
• Do not stop taking this medication without consulting your physician.
• If you are pregnant, planning to become pregnant, or breastfeeding, consult your physician before use. Domperidone is not recommended during breastfeeding for lactation stimulation.
• If you miss a dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose.
• Keep all medical appointments for monitoring of your condition.
• Store at 15–30°C in a dry place. Keep out of reach of children.

Alternative Treatment Options

• Metoclopramide (Maxeran): A dopamine antagonist with prokinetic and antiemetic properties. Available in Canada in oral and injectable forms. It crosses the blood-brain barrier and may cause extrapyramidal side effects. Domperidone has significantly fewer CNS side effects compared to metoclopramide.
• Ondansetron (Zofran): A 5-HT3 receptor antagonist commonly used for nausea and vomiting, particularly chemotherapy-induced and postoperative. Available in oral, orally disintegrating, and injectable forms.
• Prochlorperazine (Stemetil): A phenothiazine antiemetic used for various causes of nausea and vomiting. Available in oral, rectal, and injectable forms.
• Dimenhydrinate (Gravol): An antihistamine antiemetic available over the counter for motion sickness and general nausea.
• Domperidone (Motilium): The subject of this article. Available in Canada as a prescription medication.

Comparison: Domperidone is distinguished from other antiemetics by its peripheral action, meaning it does not easily cross the blood-brain barrier and therefore has a lower risk of central nervous system side effects such as drowsiness and extrapyramidal symptoms compared with metoclopramide. However, it carries a risk of QT prolongation and serious cardiac arrhythmias, particularly at higher doses or when used with interacting medications. Domperidone should be considered as an alternative prokinetic agent when metoclopramide is contraindicated or not tolerated. Your physician will determine the best option for your specific condition.

Legal Status, Registration, and Coverage in Canada

• Registration: Domperidone is authorized for sale in Canada by Health Canada as a prescription drug. It has been marketed in Canada since 1985. The brand-name Motilium has been cancelled post-market. Numerous generic formulations are available in 10 mg tablets from multiple manufacturers, including Jamp Pharma (JAMP-DOMPERIDONE, DIN 02543435), Apotex (Apo-Domperidone), Teva Canada (Teva-Domperidone), Pharmascience (PMS-Domperidone), Sivem Pharmaceuticals, Pro Doc Limitée, and Pharmaris Canada.
• Prescription Status: Prescription only in Canada.
• Coverage: Coverage varies by province, territory, and private insurance plan. In Quebec, domperidone is covered under the RAMQ formulary. In Ontario, domperidone is listed as a General Benefit on the Ontario Drug Benefit (ODB) formulary. Generic formulations are generally more affordable than brand-name products.
• Pharmacovigilance: Adverse reactions should be reported to Health Canada's MedEffect Canada program.

Recent Research and Clinical Guidelines (2022–2026)

• Health Canada completed a safety review assessing the potential risk of psychiatric withdrawal events when domperidone is used off-label for lactation stimulation. The review found a link between the sudden discontinuation or tapering of domperidone used for this purpose and the risk of psychiatric withdrawal events, including depression, anxiety, and insomnia. This link was mostly observed in patients taking daily doses greater than the maximum recommended dose of 30 mg per day. Health Canada will work with manufacturers to update the product safety information in the Canadian product monograph.
• The American Gastroenterological Association recommends starting with 10 mg three or four times daily as the initial therapeutic dose for gastroparesis symptoms. The American Heart Association recommends that doses above 10 mg three times daily are not recommended due to QT prolongation risk.
• The American College of Cardiology recommends obtaining a baseline ECG to assess QTc interval before initiating therapy and correcting electrolyte abnormalities before starting treatment.
• The American Diabetes Association suggests that domperidone should be considered as an alternative prokinetic agent when metoclopramide is contraindicated or not tolerated.
• Sunshine Biopharma received FDA-equivalent clearance in Canada for domperidone to treat cancer-related nausea in 2025.
• A drug shortage of JAMP-DOMPERIDONE 10 mg tablets was reported in October 2025 due to a demand increase for the drug, with an estimated end date of January 31, 2026. The shortage was resolved on January 30, 2026. Another shortage of domperidone 10 mg tablets from Sanis Health was reported in December 2025 due to a disruption in the manufacture of the drug.

Availability and Supply in Canada

Prices and availability may vary by province, territory, and pharmacy. Drug shortages for domperidone 10 mg have been reported in 2025 and 2026, but the JAMP-DOMPERIDONE shortage was resolved in January 2026. Check with your local pharmacy for current pricing and availability.

Frequently Asked Questions (FAQ)

1. What is domperidone used for?
   Domperidone is used to treat symptoms of slowed stomach emptying seen in people with some gastrointestinal disorders (such as gastritis) and to prevent symptoms such as nausea and vomiting caused by some drugs used to treat Parkinson's disease. It is also commonly used off-label for chemotherapy-induced nausea and vomiting.
2. How long can I take domperidone?
   The maximum recommended treatment duration is generally one week for acute nausea and vomiting. For gastroparesis, evaluate efficacy after 4 to 8 weeks to determine if continuation is warranted. Use the lowest effective dose for the shortest possible duration.
3. What is the correct dose of domperidone 10 mg?
   The recommended adult dose is one 10 mg tablet up to three times daily, with a maximum dose of 30 mg per day. Take it 15 to 30 minutes before meals.
4. Can I take domperidone with food?
   Domperidone should be taken before meals. If taken after meals, absorption is somewhat delayed. Taking it before meals ensures that the medication is activated when the stomach is most active.
5. What should I do if I miss a dose?
   If you miss a dose, skip the missed dose and resume your usual dosing schedule. Do not take a double dose to make up for a forgotten dose.
6. Can I drink alcohol while taking domperidone?
   No direct interaction has been established, but alcohol may worsen gastrointestinal symptoms. Avoid excessive alcohol consumption while taking domperidone.
7. What are the serious side effects of domperidone?
   Serious side effects include QT prolongation (which can lead to irregular heartbeats), ventricular arrhythmias, Torsade de Pointes, and sudden cardiac death. The risk may be more likely in those over 60 years old or taking doses higher than 30 mg per day. Seek immediate medical attention if you experience palpitations, fainting, or an irregular heartbeat.
8. Is domperidone safe during pregnancy?
   Domperidone should be used during pregnancy only if clearly necessary. Consult your physician if you are pregnant or planning to become pregnant.
9. Is domperidone safe during breastfeeding?
   Domperidone is not authorized in Canada to promote lactation. It is not recommended during breastfeeding for lactation stimulation. It passes into breast milk and may cause adverse reactions in the infant. Health Canada has reviewed the risk of psychiatric withdrawal events with this off-label use.
10. Are there generic versions of domperidone available in Canada?
    Yes. Generic domperidone is widely available in Canada in 10 mg tablets from multiple manufacturers, including Jamp Pharma, Apotex, Teva Canada, Pharmascience, Sivem Pharmaceuticals, and Pro Doc Limitée.
11. Why was Motilium discontinued in Canada?
    The brand-name Motilium has been cancelled post-market. However, generic domperidone products remain available as prescription medications.

How to buy Generic Domperidone without rx in Canada.